U.S. approves gene therapy treatment for hemophilia

26 avril 2024 | Agence France-Presse
Pharmaceutical giant Pfizer has received U.S. approval for a gene therapy against a form of hemophilia, a rare and inherited blood clotting disorder, the company said Friday. Beqvez, which is given as a single intravenous infusion, was shown in a clinical trial of 45 people to be better at (...)
 Site référencé:  Raw Story

Raw Story 

'Loathsome' : Fox host’s 'what up, my Nazi ?' rant slammed by civil rights icon
16/07/2025
House GOP gripes as MAGA hits members with 'overwhelming' crush of Epstein calls
16/07/2025
'Angrier by the minute' : Trump's insults 'not going to sit well' with MAGA base
16/07/2025
'What more can she do ?' Trump launches angry tirade defending Bondi
16/07/2025
'Maybe it was the autopen' : Trump mocked for forgetting he made key hire
16/07/2025
'Stupid Republicans !' Trump blasts own party as Oval Office meeting derails
16/07/2025